Article
India’s Draft Biotechnology Patent Guidelines (2026): What Pharma & Biotech Brand Owners Need To Know
India has redrawn how it examines biotech patents for the first time since 2013. If you own a portfolio in pharma, biologics, biosimilars or diagnostics, the draft changes what will get granted in India — and what won’t.

S.S. Rana & Co.
